Zacks Research Forecasts Maximus’ FY2028 Earnings (NYSE:MMS)

Maximus, Inc. (NYSE:MMS) – Research analysts at Zacks Research issued their FY2028 EPS estimates for shares of Maximus in a research note issued on Thursday, December 11th. Zacks Research analyst Team anticipates that the health services provider will post earnings per share of $8.95 for the year. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Maximus’ current full-year earnings is $6.15 per share.

Separately, Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a research report on Monday. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $90.00.

Maximus Stock Up 1.4%

NYSE:MMS opened at $87.73 on Monday. The firm has a market capitalization of $4.78 billion, a PE ratio of 15.78 and a beta of 0.56. The stock has a 50 day moving average of $84.58 and a 200-day moving average of $81.00. Maximus has a 52 week low of $63.77 and a 52 week high of $92.50. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a net margin of 5.87% and a return on equity of 25.23%. The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same period in the prior year, the company earned $1.46 EPS. Maximus’s quarterly revenue was up .2% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, December 1st. Stockholders of record on Friday, November 14th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend was Friday, November 14th. Maximus’s dividend payout ratio (DPR) is 21.58%.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 4,039 shares of Maximus stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider directly owned 19,542 shares in the company, valued at $1,697,027.28. The trade was a 17.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Dimensional Fund Advisors LP boosted its stake in shares of Maximus by 2.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock worth $170,812,000 after acquiring an additional 36,989 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its position in Maximus by 40.0% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock valued at $117,921,000 after purchasing an additional 494,372 shares during the last quarter. AQR Capital Management LLC grew its stake in Maximus by 177.2% in the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock valued at $79,341,000 after purchasing an additional 750,031 shares in the last quarter. Boston Partners increased its position in Maximus by 47.0% in the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after purchasing an additional 308,892 shares during the last quarter. Finally, Reinhart Partners LLC. raised its stake in shares of Maximus by 0.8% during the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider’s stock worth $84,206,000 after purchasing an additional 7,722 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.